SAN DIEGO, May 20 /PRNewswire-FirstCall/ — Volcano
Corporation (Nasdaq: VOLC) announced today the completion of the first
clinical cases using the new Eagle Eye® Platinum digital IVUS
catheter. The procedures were performed in seven centers within
the United States. Commercial
launch of Eagle Eye® Platinum in the U.S. is expected in June 2010.
(Photo: http://www.newscom.com/cgi-bin/prnh/20100520/SF08130)
“Our customer research of the most important IVUS catheter
features found that both improved deliverability and the ability to
easily estimate lesion length were vital,” commented David Sheehan, President of Volcano’s IVUS
and Physiology Business Units. “We designed the Eagle Eye®
Platinum to directly meet those needs. Deliverability was addressed
with a more tapered tip, smoother design, and proprietary new
GlyDx™ hydrophilic coating. The overwhelming response in
clinical use thus far is that there is a remarkable difference
physicians can feel, even through stents and challenging lesions.
Plus, the three new radiopaque markers provide instant information,
facilitating a more precise lesion length estimate, right on the
angiogram.”
After conducting one of the first clinical cases with Eagle
Eye® Platinum, Dr. Craig
Thompson, Associate Professor of Internal
Medicine/Cardiology at Yale-New Haven Ho
‘/>”/>
SOURCE